devdiscourse2h
India to Open New Consulates in Boston and Los Angeles, Meeting Long-Pending Community Demand
Prime Minister Narendra Modi announced the opening of two new Indian consulates in Boston and Los Angeles, addressing a ...
Glenmark’s Telma H, Sun Pharma’s Ursocol 300 among 16 drugs termed spurious
The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...
Orchid AMS eyes Rs 300 cr turnover in 3 years for antimicrobial resistance
Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...
devdiscourse13h
Orchid Pharma's New Antimicrobial Solutions Division Targets Rs 300 Crore Turnover
Orchid Pharma's new Antimicrobial Solutions division aims to achieve a turnover of Rs 300 crore in three years, tackling ...
Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult pati…
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
FiercePharma2d
Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
STAT2d
Are generalist investors good or bad for biotech?
Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...
kffhealthnews2d
FDA Catches Indian Drugmaker Destroying Crucial Inspection Papers
The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...
FiercePharma2d
In addressing inspection shortfall, FDA says it's gaining more inspectors than it's losing
In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA ...
India's Nifty, Sensex Outperform Most Global Markets, Behind Only Wall Street
BENGALURU (Reuters) - India's NSE Nifty 50 and S&P BSE Sensex are trailing only Wall Street's Nasdaq and S&P 500 as ...
Indian shares set to open higher on US rate-cut euphoria
Indian shares are set to open higher on Friday, as an outsized interest rate reduction by the U.S. Federal Reserve and the ...
Department of pharmaceuticals doubles financial incentives for drug makers to their upgrade plants
The department of pharmaceuticals has doubled the financial incentive to ₹2 crore for drug manufacturers to upgrade their ...